Improvements were confirmed by reduced symptom scores, lower serum total and OVA-specific IgE levels (ELISA), decreased Th2 cytokine expression (RT-PCR), diminished mucosal eosinophilia and goblet cell hyperplasia (histology), and enhanced Foxp3 expression in nasal tissues (immunofluorescence). Here, FOXP3 is linked to Increased total eosinophil count.